Trademark: 85332656
Status Date
Friday, April 7, 2023
Registration Number
4214952
Registration Date
Tuesday, September 25, 2012
Filing Date
Friday, May 27, 2011
Published for Opposition
Tuesday, May 15, 2012
Cancellation Date
Friday, April 7, 2023
42 Medical and scientific research, namely, conducting clinical trials for testing the safety and effectiveness of rituximab and lenalidomide
Apr 7, 2023
Cancelled Sec. 8 (10-Yr)/Expired Section 9
Sep 25, 2021
Courtesy Reminder - Sec. 8 (10-Yr)/Sec. 9 E-Mailed
Oct 19, 2017
Notice Of Acceptance Of Sec. 8 & 15 - E-Mailed
Oct 19, 2017
Registered - Sec. 8 (6-Yr) Accepted & Sec. 15 Ack.
Oct 17, 2017
Case Assigned To Post Registration Paralegal
Sep 25, 2017
Teas Section 8 & 15 Received
Sep 25, 2017
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Jul 29, 2015
Teas Change Of Correspondence Received
Sep 25, 2012
Registered-Principal Register
Aug 22, 2012
Notice Of Acceptance Of Statement Of Use E-Mailed
Aug 21, 2012
Law Office Registration Review Completed
Aug 15, 2012
Allowed Principal Register - Sou Accepted
Aug 9, 2012
Statement Of Use Processing Complete
Jul 17, 2012
Use Amendment Filed
Aug 8, 2012
Case Assigned To Intent To Use Paralegal
Jul 17, 2012
Teas Statement Of Use Received
Jul 10, 2012
Noa E-Mailed - Sou Required From Applicant
May 15, 2012
Official Gazette Publication Confirmation E-Mailed
May 15, 2012
Published For Opposition
Apr 25, 2012
Notification Of Notice Of Publication E-Mailed
Apr 9, 2012
Law Office Publication Review Completed
Apr 3, 2012
Approved For Pub - Principal Register
Mar 3, 2012
Teas/Email Correspondence Entered
Mar 3, 2012
Correspondence Received In Law Office
Feb 28, 2012
Assigned To Lie
Feb 10, 2012
Teas Response To Office Action Received
Sep 13, 2011
Notification Of Non-Final Action E-Mailed
Sep 13, 2011
Non-Final Action E-Mailed
Sep 13, 2011
Non-Final Action Written
Sep 13, 2011
Assigned To Examiner
Jun 2, 2011
New Application Office Supplied Data Entered
May 31, 2011
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
